Critical to SNARE protein function in neurotransmission are the accessory proteins, SNAP and NSF, which play a role in activation of the SNAREs for membrane fusion. In this report, we demonstrate the depolarization-induced, calcium-dependent phosphorylation of NSF in rat synaptosomes. Phosphorylation of NSF is coincident with neurotransmitter release and requires an influx of external calcium. Phospho-amino acid analysis of the radiolabeled NSF indicates a role for a serine/threonine specific kinase. Synaptosomal phosphorylation of NSF is stimulated by phorbol esters and is inhibited by staurosporine, chelerythrine, bisindolylmaleimide I, calphostin C, and Ro31-8220, but not the CaM kinase II inhibitor, Kn-93, suggesting a role for protein kinase C (PKC). Indeed, NSF is phosphorylated by PKC in vitro at Ser-237 of the catalytic D1 domain. Mutation of this residue to Glutamic acid or to Alanine eliminates in vitro phosphorylation. Molecular modeling studies suggest that Ser-237 is adjacent to an intersubunit interface at a position where its phosphorylation could affect NSF activity. Consistently, mutation of Ser-237 to Glu, to mimic phosphorylation, results in a hexameric form of NSF that does not bind to SNAP/SNARE complexes, while the S237A mutant does form complex. These data suggest a negative regulatory role for PKC phosphorylation of NSF. (200 words) Matveeva et al. The molecular mechanisms of neurotransmitter (NT) 1 release have been the subject of much attention in recent years resulting in an evolving model known as the SNARE hypothesis (1-3). The SNARE hypothesis holds that membrane proteins in the vesicle (v-SNAREs, e.g. synaptobrevins) bind to a heterodimer in the target membrane (t-SNAREs, heterodimers of syntaxins and SNAP-25-like proteins). V-and t-SNAREs bind to form a 7S complex (1,4), composed of a bundle of four parallel, coiled-coil domains (5-8) which, through reconstitution studies, has been demonstrated to be minimally required for bilayer fusion (9). The Nethylmaleimide Sensitive Factor (NSF) and the Soluble NSF Attachment Proteins (SNAPs, not to be confused with SNAP-25) affect the composition and structure of the SNARE complex.
subsequent stimulations (21) (22) (23) . These data are consistent with a role for NSF in maintaining a "ready-release" pool of synaptic vesicles, which is competent for fast response to calcium influx.
Consistently, SNAPs, when injected into crayfish axons, increase the probability of neurotransmitter release but not the rate (24) . On a molecular level, these data support the model that NSF functions prior to neurotransmitter release to activate SNAREs for membrane fusion and perhaps after fusion to recycle spent SNAREs (25) .
NSF is a homo-hexameric ATPase whose subunits can be divided into three domains (N, D1 and D2) (11, 26, 27) . The N-terminal domain is required for binding to the SNAP/SNARE complex. ATP binding and hydrolysis by D1 is essential for NSF activity. Mutants in the D1 domain that fail to bind ATP also fail to interact with SNAP/SNARE complex (27) . D1 mutants that fail to hydrolyze ATP are dominant negative inhibitors because they fail to disassemble 7S SNARE complexes (11, 27, 28) . The D2 domain is required for hexamerization since its deletion yields a monomer (11) . Though this domain has high affinity for ATP and low ATPase activity, neither function is essential for NSF activity (11, 29) . In a current model of NSF structure, the hexameric D2 domain anchors the catalytically active D1 domains and SNAP/SNARE-binding N domains.
Much work has focused on the role of phosphorylation by protein kinase C (PKC) in the control of neurotransmission (reviewed in (30) ). In particular, it has clearly been shown that activation of PKC by phorbol esters can lead to an enhancement of L-glutamate release (31) (32) (33) (34) .
Several studies indicate that PKC translocation from cytosol to membrane is associated with both PKC activation and enhanced L-glutamate release (32, 35, 36) . Moreover, phosphorylation of PKC substrates that are selectively localized in nerve terminals, such as B-50/GAP-43 and (37) (38) (39) . Among candidate protein targets for PKC that have received scrutiny are those involved in the docking/fusion process. In one such study, activation of PKC by phorbol esters induced phosphorylation of SNAP-25 and increased depolarization-dependent norepinephrine release from PC12 cells (40) . That study and others (reviewed in (30) ) have demonstrated a potential role for PKC in neuroendocrine secretion but have yielded little molecular insight into the precise effects of phosphorylation. Several studies have attempted to fill this gap by focusing on the components of the membrane fusion machinery (e.g. SNARE, SNAPs and NSF). Those studies have demonstrated that various machinery elements can be phosphorylated in vitro with purified kinases (e.g. PKA, PKC, CaMKII) and that the phosphorylation does affect their protein-protein interactions (30) .
In the present study, we provide the first demonstration of depolarization-induced, respectively. Horseradish peroxidase conjugated, anti-immunoglobulin secondary antibodies were from Sigma. Polyethyleneimine cellulose plates for thin layer chromatography were from Selecto Scientific (Norcross, GA). Glutathione immobilized on cross-linked 4% beaded agarose was from Sigma. Calmodulin was purified from bovine testis as described previously (41) . All chemicals were reagent grade.
Wild type NSF and NSF mutants were produced as recombinant proteins in E. coli and purified as described (27) . Production of His 6 -free NSF was accomplished using the pPROExHt expression system and the TEV protease (Life Technologies, Rockville, MD). Site directed mutagenesis was accomplished using the QuickChange kit according to manufacturer's instructions (Stratagene, La Jolla CA) and mutations were confirmed by dideoxy nucleotide sequencing. His 6 -α-SNAP, His 6 -γ-SNAP, and GST-syntaxin 1 (cytosolic domain 1-265 a.a.)
were produced as recombinant proteins in E. coli and purified as described (7, 27) . Protein concentrations were measured with the BioRad protein assay reagent (BioRad, Hercules CA) using ovalbumin as a standard. The anti-NSF monoclonal (2E5) and polyclonal antibodies were described previously (11, 27) . The anti-α-SNAP antibody was from Gamma One Laboratories (Lexington, KY).
Bath Experiments with Synaptosomes. An in situ preparation of Percoll-gradient purified rat cerebral cortical synaptosomes (42) was used to measure both K + -evoked, Ca 2+ -dependent NSF phosphorylation and NT release. The composition of all buffers has been described (43) .
Synaptosomes were resuspended in Krebs/sucrose buffer without phosphate and incubated with 32 Pi (7,000 Ci/mmole) for 30 min at 37° under 95%O 2 , 5%CO 2 . 32 Pi -loaded synaptosomes were then placed in Krebs/Ringer bicarbonate buffer with either 1.5 mM Ca 2+ or 10 mM Mg 2+ .
Samples were depolarized by addition of K + (25 mM final concentration) and the process was stopped at 30 sec by the addition of SDS/ortho-vanadate (8) . L-glutamate release was measured in parallel samples using an enzyme coupled fluorometric assay (44, 45) . Synaptosomes were depolarized on addition of 25 mM KCl to an incubation mixture containing NADP (1 mM), glutamate dehydrogenase (50 U/ml), and either CaCl 2 (1.5 mM) or MgCl 2 (10 mM). NADPH fluorescence was monitored using excitation and emission wavelengths of 340 and 460 nm respectively. Data were accumulated at 1 sec intervals using a Perkin-Elmer LS5B spectrofluoremeter fitted with stirred, thermostatted cuvettes at 37º.
Immunoprecipitation of NSF.
Prior to immunoprecipitation (IP), Triton X-100 was added to the solubilized samples to neutralize the SDS. Samples were then diluted in IP buffer (10 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 0.2 mM sodium o-vanadate, 0.2 mM phenylmethyl-sulfonyl fluoride) and Protein G Sepharose beads with covalently coupled anti-NSF antibody were added (46) . NSF was immunoprecipitated by incubation for 1 h at 4°C. The beads were harvested and washed 5 times in 0.5 mL of IP buffer; the protein- Figure 1A (Ca Rel) and subjected to 2D-TLE phosphoamino acid analysis following acid hydrolysis (48) . Both phosphoserine and phosphothreonine, but not phosphotyrosine, were detected from this in situ labeled NSF (Figure 2A ). This suggests the involvement of one of the many neuronal Ser/Thr protein kinases (i.e. PKC, PKA, CaMKII). NSF contains potential kinase recognition sites for PKC, CaMKII, and casein kinase II but does not have consensus PKA sites.
When recombinant NSF was labeled in vitro with purified PKC, phosphoamino acid analyses showed the presence of only phosphoserine ( Figure 2B ). Experiments have shown that CaMKII, but not PKA or casein kinase II can modify NSF in vitro ((49) and see Figure 3 ). Protein kinase inhibitors were used to further examine the kinase(s) responsible for NSF phosphorylation in synaptosomes. Figure 2C shows that the depolarization-dependent phosphorylation of NSF was inhibited by the inclusion 5 µM staurosporine, but not by the addition of 4 µM Kn-93, which is 10 times the reported K i for CaM kinase II (50) . Other inhibitors, more specific for protein kinase C also affected phosphorylation. Bisindolmaleimide I (100 nM), calphostin C (500 nM), chelerythrine (6.6 µM) and Ro31-8220 (100 nM) inhibited NSF phosphorylation by between 55% for chelerythrine and 80% for calphostin C ( Figure 2D ). The appearance of phospho-NSF was not enhanced significantly by 1 µM okadaic acid suggesting that protein phosphatases 1 and 2A may not be involved in NSF dephosphorylation. Treatment of synaptosomes with the PKC activator PMA (0.16 µM) increased NSF phosphorylation by 77% in the presence of EGTA and by 61% in the presence of calcium ( Figure 2C ). Under these same conditions, PMA did not stimulate glutamate release, however it did enhance both the extent of release (199.7±32.9 versus 126.3±12.0 pmole/mg synaptosome protein (p= 0.05)) and the initial rate of release (253.8±43.6 versus 126.8±18.6 pmole/mg synaptosome protein/min (p=0.03)).
Characterization of NSF and SNAP Phosphorylation in vitro.
Previous studies (49) reported that CaMKII can phosphorylate NSF in vitro, however, PKC was not tested. To reconcile those studies with present data, the ability of purified rat brain-derived CaMKII and PKC to Matveeva et http://www.jbc.org/ Downloaded from major radiolabeled peak (other than the unabsorbed fraction containing inorganic phosphate) was observed in each case. However, the tryptic fragment eluted early in the acetonitrile gradient, commensurate with a small peptide, while the Lys C product eluted much later, as expected for a longer peptide. Radiochemical sequencing of the trypsin fragment isolated from the separation shown in Figure 4A gave release of the bulk of the 32 P at cycle 4 (data not shown) whereas release of radiolabel on degradation of the Lys C phosphopeptide was observed after cycle 4 and cycle 12 as shown in Figure 4B . These data suggest that the phosphorylated serine in the recombinant NSF was 4 residues from an Arginine or Lysine (trypsin digest) and 12 residues from a Lysine (Lys C digest). [It should be noted that the primary sequence detected on PTHamino acid analysis of these fractions was that for the amino terminal portion of the recombinant molecule containing the His 6 -tag preceded by the sequence MRGS. Removal of this tag by TEV protease digestion however did not lead to a significant reduction in in vitro phosphorylation (data not shown)]. The only residue that completely fulfills these criteria, Ser-237, is part of the sequence RRAFASRVF that is a non-canonical PKC recognition site but is conserved in 17 of the 18 NSF sequences in the database. To demonstrate that this serine was phosphorylated in vitro, site-directed mutagenesis was used to change the residue to either an Alanine or a Glutamate. The resulting S237A and S237E mutant forms of NSF retain native oligomeric structure (see below), but are not phosphorylated significantly by PKC in vitro as shown in Figure 4C . Thus, Ser-237 is the only modification site consistent with the radiochemical sequencing data and its mutation results in a non-phosphorylatable form of NSF. Figure   4D ). The lack of binding is most likely due to the introduction of a negative charge at S237 since another mutant, S237A showed wild-type levels of SNAP/SNARE binding. This defect in SNAP/SNARE binding is consistent with an inability of the NSF molecule to attain a binding competent conformation. Such binding incompetence occurs when NSF is in the ADP-bound form (29) and has been seen in mutants that lack or have mutations in the N-domain ( (27) and Matveeva et al. in preparation) or that are unable to bind nucleotide in the D1 domain (27) .
Discussion:
In this study, we demonstrate a depolarization-induced phosphorylation of NSF in rat synaptosomes that is dependent on influx of Ca 2+ into the synaptosome. Phosphoamino acid analysis of radiolabeled NSF shows the presence of phosphoserine and phosphothreonine but no phosphotyrosine suggesting a role for a neuronal Ser/Thr kinase. Previous work has shown that in a position to greatly affect the flexibility of the catalytic D1 domain (see below). Our observations are the first of which we are aware that connect control of a physiologic process to a phosphorylation event involving a protein of the docking/fusion apparatus. They are significant because they indicate that in response to depolarization, synaptosomal PKC may down-regulate NSF activity by effecting its ability to interact with its substrates, SNAPs and SNAREs. We were able to document this phosphorylation because the synaptosomal preparation offers an isolated region of the cell where the docking/fusion components involved in neurotransmitter release are concentrated; 0.5 to 1% of the total synaptosomal protein is NSF.
Role of PKC in Neurotransmission.
Numerous studies have shown a presynaptic role for PKC in neurotransmission (for a recent review see (30) ). It is generally accepted that activation of PKC, isozymes with physiologic processes (e.g., LTP) and pathologic processes (e.g., kindled epilepsy). Thus LTP of synaptic transmission in the hippocampus, a model of learning and memory (for review see (51)), has been associated with PKC translocation to the membrane (35, 52) and to phosphorylation by PKC of F1/GAP-43 (53) . Similarly, kindled epilepsy evoked by stimulation at multiple brain sites has been associated with both transient (54, 55) and longterm (56, 57) increases in membrane-associated PKC enzyme activity but not protein levels.
However, no direct association has been made between enhanced glutamate release associated with LTP or kindling and phosphorylation of the secretory machinery (43, 58) . Our studies provide the first evidence for the linkage between phosphorylation of secretory machinery, namely NSF, and neurotransmitter release and also provide a potential site for alteration in LTP and kindling.
To date, SNAP-25 (40, 59, 60) , syntaxins (60-62), αand γ-SNAPs (49), Munc18 (63,64), synaptotagmins (65, 66) , and now NSF are substrates for PKC at least in vitro. In most of these reports the PKC-mediated phosphorylation prevents the association of proteins (i.e. phospho-Munc18a and syntaxin-1 (63) or phospho-α-SNAP and syntaxin-1 (49)). In this report, this also appears to be true based on the behavior of the S237E mutant NSF, which cannot bind to the SNAP/SNARE complex. At this point, it is unclear how these PKC-mediated phosphorylation events can regulate the secretory cycle in the synaptosome. Here, we report depolarization-dependent phosphorylation of NSF that requires calcium influx, suggesting that NSF phosphorylation occurs after exocytosis. The physiological role of this modification in controlling NSF function is yet to be determined. (22, 23, 67) .
Molecular analysis of the effects of NSF phosphorylation. Two models of NSF function in
However, in a more recent study, inactivation of NSF through the addition of N-ethylmaleimide was shown to increase the pool of hyperosmotically-sensitive synaptic vesicles (68) . This pool is thought to be equivalent to the kinetically defined "ready-release" pool. In this second model, inhibition of NSF is thought to block disassembly of trans-SNARE complexes thereby maintaining the functional complexes for membrane fusion. In these two models, NSF inactivation by phosphorylation could lead to distinct outcomes. Based on the first model, Structurally, phosphorylation of NSF at Ser-237 could have rather drastic effects. Since no crystal structure is available for the D1 domain of NSF, we must use the structure of the homologous, but not identical, D2 domain as the basis for discussion. By structure-based sequence alignments (69), Ser-237 would be in the middle of the α1 helix, which is solventaccessible and is adjacent to the inter-subunit interface that is important for hexamerization.
This residue (Ser-237) is well within 15 Å of the adjacent subunit particularly the loop between the α8 and α9 helices. Such a position could be important since the α8 helix has several key residues that make contacts with the ATP nucleotide (red, Figure 5B ) and with the adjacent subunit (yellow, Figure 5B ). Phosphorylation at Ser-237 could affect the positioning or flexibility of the α8 and therefore the conformational changes associated with ATP hydrolysis or with nucleotide exchange. When one models in the residues that are present in the predicted α8-α9 loop of D1, the potential for an effect becomes more striking ( Figure 5B ). This region of D1 has a net higher positive charge than the corresponding region of D2 ( Figure 5A ) with the Arg-463 and Lys-466 being within 9 Å of the phospho-amino acid (or the modeled Glu in Figure   5B ). This is well within the reach of charge influences from a negatively charged phosphate on the adjacent subunit. Such charge-charge interactions could restrict the movement of the α8 
